Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies general Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies admin November 26, 2025 Pharma companies are facing pricing pressure from several directions, including from the U. S. Medicare negotiations. Read More Read more about Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
